OXFORD, United Kingdom, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and infectious diseases, announces that management will participate in two upcoming investor conferences in New York City, US.

  • BIO CEO & Investor Conference – 12 February 2018, presentation at 3:15pm EST
  • SunTrust Robinson Humphrey 4th Annual Orphan Drug Day – 13 February 2018

A live audio webcast of the BIO CEO presentation will be available through the Investors section on the Company’s website, www.summitplc.com. A replay of the webcast will be available from the same location soon after the live presentation. For the SunTrust Robinson Humphrey Orphan Drug Day, the Company will participate in one on one meetings.

About Summit Therapeutics
Summit is a biopharmaceutical company focused on the discovery, development and commercialisation of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease, Duchenne muscular dystrophy, and the infectious disease, Clostridium difficile infection. Further information is available at www.summitplc.com and Summit can be followed on Twitter (@summitplc).

For more information, please contact:

    
Summit   
Glyn Edwards / Richard Pye (UK office)Tel: 44 (0)1235 443 951
Erik Ostrowski / Michelle Avery (US office)  +1 617 225 4455
    
Cairn Financial Advisers LLP (Nominated Adviser)Tel: +44 (0)20 7213 0880
Liam Murray / Tony Rawlinson   
    
N+1 Singer (Joint Broker)Tel: +44 (0)20 7496 3000
Aubrey Powell / Jen Boorer   
    
Panmure Gordon (Joint Broker)Tel: +44 (0)20 7886 2500
Freddy Crossley / Duncan Monteith, Corporate Finance   
Tom Salvesen, Corporate Broking   
    
MacDougall Biomedical Communications (US)Tel: +1 781 235 3060
Karen Sharma  ksharma@macbiocom.com
    
Consilium Strategic Communications (UK)Tel: +44 (0)20 3709 5700
Mary-Jane Elliott / Sue Stuart /  summit@consilium-comms.com
Jessica Hodgson / Philippa Gardner   


-END-

Ads